Journal Information

Statistics

Follow this link to access the full text of the article

Research Letter
Starting sacubitril-valsartan is safe in patients with transthyretin cardiac amyloidosis and impaired ejection fraction
O início do tratamento com sacubitril-valsartan é seguro em doentes com amiloidose cardíaca transtirretina e fração de ejeção reduzida
Martin Negreira-Caamañoa, Jorge Martínez-Del Ríoa, Alfonso Morón-Alguacila, Pedro Pérez-Díaza,b, Jesus Piqueras-Floresa,b,c,
a Cardiology Department, University General Hospital of Ciudad Real, Spain
b Cardiomyopathies and Inherited Disease Unit, Cardiology Department, University General Hospital of Ciudad Real, Spain
c Medicine Faculty, Castilla La-Mancha University, Ciudad Real, Spain
Read
3451
Times
was read the article
1114
Total PDF
2337
Total HTML
Share statistics
Article information
ISSN: 08702551
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 9 118 39 157
2025 8 150 66 216
2025 7 118 55 173
2025 6 80 28 108
2025 5 149 38 187
2025 4 100 43 143
2025 3 98 22 120
2025 2 75 19 94
2025 1 60 30 90
2024 12 64 38 102
2024 11 80 39 119
2024 10 69 54 123
2024 9 85 41 126
2024 8 70 39 109
2024 7 52 26 78
2024 6 40 34 74
2024 5 49 27 76
2024 4 50 29 79
2024 3 46 28 74
2024 2 51 26 77
2024 1 33 18 51
2023 12 33 22 55
2023 11 56 39 95
2023 10 49 12 61
2023 9 42 27 69
2023 8 53 15 68
2023 7 65 15 80
2023 6 62 12 74
2023 5 70 39 109
2023 4 58 21 79
2023 3 67 24 91
2023 2 91 84 175
2023 1 39 32 71
2022 12 15 33 48
Show all

Follow this link to access the full text of the article

Idiomas
Revista Portuguesa de Cardiologia (English edition)
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos